Instrument Inactif

Autres langues Sophiris Bio, Inc. Other OTC

Actions

SPHS

CA83578Q2099

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Swiss franc rises to six year high as central bank stands back	30/11/21
Sophiris Bio : Swiss c.bank diverges from peers to stick with ultra-loose monetary course	23/09/21
Sophiris Bio : Reports Fourth Quarter and Full Year 2016 Financial Results and Key Corporate Highlights	27/03/17
Sophiris Bio : Reports Second Quarter 2016 Financial Results and Key Business Highlights	09/08/16
Sophiris Bio : Reports First Quarter 2016 Financial Results and Key Business Highlights	16/05/16
Sophiris Bio : To Present Topsalysin Phase 3 Data from Positive PLUS-1 Study as a Late Breaking Poster During the 111th American Urological Association Annual Meeting	05/05/16
Sophiris Bio, Inc. Announces Joseph L. Turner Would Not Be Stand for Re-Election at the Annual General Meeting	29/04/16
Sophiris Bio, Inc. Auditor Raises 'Going Concern' Doubt	29/03/16
Sophiris Bio, Inc. Reports Unaudited Consolidated Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2015	23/03/16
Sophiris Bio, Inc. Reports Encouraging Preliminary Data from Phase 2A Proof of Concept Study in Localized Prostate Cancer	28/01/16
Sophiris Bio, Inc. announced that it has received $2.8 million in funding from Aspire Capital Partners, LLC	31/12/15
Sophiris Bio : Reports Third Quarter Financial Results and Business Highlights	09/12/15
Sophiris Bio : Phase 3 BPH Study Successfully Meets Primary Endpoint	09/12/15
Sophiris Bio, Inc. Reports Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended September 30, 2015	16/11/15
Sophiris Bio Phase 3 BPH Study Successfully Meets Primary Endpoint	10/11/15
Sophiris Bio : Reports Second Quarter Financial Results	13/08/15
Sophiris Bio, Inc. Announces Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2015	13/08/15
Sophiris Bio : to Present at the LD Micro Invitational Conference	27/05/15
Sophiris Bio : Enrolls First Patients in Phase 2a Proof of Concept Prostate Cancer Study	26/05/15
Sophiris Bio, Inc. Enrolls First Patients in Phase 2a Proof of Concept Prostate Cancer Study	26/05/15

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Sophiris Bio, Inc. Other OTC

Actions

SPHS

CA83578Q2099

Autres langues

Filtres